Merck's (MRK) Suvorexant Helps People Sleep, Says FDA
Merck's (NYSE: MRK) Suvorexant helps people sleep, said an FDA panel.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) Receives Positive CHMP Opinion for SIVEXTRO
- EMD Millipore Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control
- FDA Approves Evotaz as HIV-1 Treatment (BMY)
Create E-mail Alert Related CategoriesFDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!